# Phase 23A End-to-End Audit

Audit date: 2026-08-30. Environment: development only. No production data or migration was used.

| Requirement | Status | Code evidence | Test evidence | Problem / fix applied | Remaining risk |
|---|---|---|---|---|---|
| Business Twin maturity and provenance | PASS | Versioned project-scoped Twin, maturity stages, evidence claims | `test:business-twin` | Existing implementation retained | None material |
| ICP modes and project scope | PASS | Hypothesis, early-evidence, and validated modes with criterion provenance | `test:icp` | Existing implementation retained | None material |
| Find My Market | PASS | Bounded Business Twin + ICP query → Provider Router `COMPANY_DISCOVERY` → canonical ingestion | `test:phase23a` | Added authenticated discovery endpoint, UI action, and Apify normalization | Live integration requires an enabled actor configured for `COMPANY_DISCOVERY` |
| Analyze My List | PASS | Preview-first CSV and manual entry; maximum 500 rows/request | `test:companies` | Added common header aliases and source records | XLSX/multi-sheet is PARTIAL; separate CSVs remain the supported path |
| Flexible column mapping | PARTIAL | Common company/domain/headcount/description aliases map deterministically | Typecheck and import tests | Expanded common aliases | Arbitrary unknown columns are retained only when submitted through provenance payload; UI does not yet offer per-column classification |
| Canonical resolution | PASS | Domain/alias exact matching, advisory locks, possible-match review | `test:companies`, `test:phase23a` | Discovery now uses the same canonical tables and domain lock | Name-only possible matches are held rather than auto-merged |
| ACME duplicate test | PASS | `company_provenance` preserves upload and discovery independently | `test:phase23a` | One domain produced one canonical company and two source records | None material |
| Provenance and public/private separation | PASS | Project/organization-scoped append-only provenance with visibility | `test:phase23a`, DB invariants | Added source records for manual, CSV, and JYRA discovery; public records exclude the private discovery query | Imported custom fields remain evidence candidates, not verified facts |
| Unified downstream pipeline | PASS | Both entry paths create/reuse `companies` + `project_companies` | Regression suites | No separate scoring path introduced | Downstream work remains intentionally selective, not automatic |
| Discovery vs research | PASS | `COMPANY_DISCOVERY` endpoint is separate from known-company Research Now | Provider and research tests | Added dedicated discovery service | None material |
| Selective research and economics | PASS | Planner, 50-company scheduled cap, reservations, provider-attempt ledger | `test:research` | Existing Phase 23 controls retained | Provider estimates must remain configured accurately |
| Fresh research | PASS | Research Now invokes configured external provider capabilities | `test:research`, `test:providers` | Existing evidence-first flow retained | Live execution is blocked when providers are unavailable |
| Evidence → facts → signals | PASS | Immutable raw pages, validated fact excerpts, approved configuration-driven signals | evidence/fact/signal tests and DB invariants | Existing boundaries retained | Model extraction can fail safely without creating facts |
| Generic signals/clusters/opportunities | PASS | Project/offering snapshots and versioned deterministic policies | signal/cluster/opportunity tests | Existing implementation retained | None material |
| WHY and Today | PASS | Persisted assessment/evidence trace and persisted Today projection | WHY and Today tests | Existing implementation retained | Unsupported claims remain excluded |
| Company-first people research | PASS | Threshold or explicit-user trigger required | buyer/contact tests | Existing implementation retained | Live contact providers may be unavailable |
| Outcomes and learning | PASS | Immutable recommendation snapshots and explicit promotion boundaries | recommendation/learning tests | Existing implementation retained | Correlation remains non-causal |
| Database environment isolation | PASS | Schema push, invariant scripts, and the Phase 23A DB-mutating integration test reject production/deployment runtime and mismatched target fingerprints before connecting | invariant tests, Phase 23A tests, and wrong-target guard commands | Added fail-closed development target guards | Production migration remains an explicit separate operational workflow |
| 200–500 company readiness | PASS | Import contract caps each preview/commit at 500 and performs no research dispatch | company tests | Preview-first behavior retained | Larger files should be chunked |
| 1,000+ market safety | PASS | Discovery is capped at 50/run; scheduled research is capped at 50; import does not dispatch research | research bounded demonstration | Existing bounded behavior retained | Full 1,000-row UI upload requires multiple batches |
| Multi-sheet relational import | PARTIAL | Separate company and future relational CSV flows fit the model | Code audit | No over-engineered XLSX layer added | Native XLSX multi-sheet import is not implemented |

## Final report

1. **Did Find My Market discover new companies?** Code pass. It invokes an external `COMPANY_DISCOVERY` provider and canonicalizes candidates. Live integration is blocked until an enabled provider actor is configured.
2. **Do uploaded and discovered companies converge?** Yes. Both use the global canonical company and project-company link tables.
3. **Did the ACME duplicate test pass?** Yes. One canonical company retained independent upload and discovery provenance.
4. **Is research selective?** Yes. Imports do not start research; discovery is bounded; scheduled research has a hard batch cap and planner stops.
5. **Does the planner consider cost?** Yes. Cost affects ranking and budget admission before dispatch.
6. **Does Research Now acquire fresh information?** Yes when a provider is configured; otherwise it fails honestly.
7. **Are evidence, facts, and signals separated?** Yes, with database and deterministic validation.
8. **Is signal intelligence generic?** Yes; meaning comes from approved project/offering configuration.
9. **Is scoring explainable?** Yes; dimensions and confidence remain separate and versioned.
10. **Does Today use persisted intelligence?** Yes.
11. **Are people enriched only after qualification?** Yes, except explicit user requests.
12. **Is recommendation history immutable?** Yes.
13. **Are development and production isolated?** Development tools now fail closed in production/deployment runtime; this audit used development only.
14. **Can 200–500 real companies be uploaded safely to development?** Yes, subject to privacy review and one 500-row batch.
15. **Can JYRA handle a 1,000-company test safely?** Yes in multiple import batches; no market-wide automatic research fan-out occurs.
16. **Remaining CRITICAL/HIGH issues:** None found. Native XLSX/multi-sheet import and interactive unknown-column classification remain non-critical PARTIAL items.
